Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
-
* Corresponding author: Steven JM Jones sjones@bcgsc.ca
Genome Biology 2010, 11:R82 doi:10.1186/gb-2010-11-8-r82
Accesses
- Last 30 days: 229 accesses
- Last 365 days: 3889 accesses
- All time: 11454 accesses
Cited by
BioMed Central: 4 citations
|
Review
Drug repositioning for personalized medicine Yvonne Y Li, Steven JM Jones Genome Medicine 2012, 4:27 (30 March 2012) Steven Jones and Yvonne Li review how drug discovery can be made more efficient by repositioning of approved drugs to treat new diseases and by identifying patients who will benefit from such treatments.
|
|
Review
'Omic approaches to preventing or managing metastatic breast cancer Obi L Griffith, Joe W Gray Breast Cancer Research 2011, 13:230 (8 December 2011) |
|
Proceedings
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes Roland Wittler, Cedric Chauve BMC Bioinformatics 2011, 12(Suppl 9):S21 (5 October 2011) |
|
Poster presentation
Eric Letouzé, Yves Allory, Marc A Bollet, François Radvanyi, Frédéric Guyon Genome Biology 2010, 11(Suppl 1):P25 (11 October 2010) |
